These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27845595)

  • 21. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation.
    Wang Q; Tan MT; Keegan BP; Barry MA; Heffernan MJ
    Biomaterials; 2014 Sep; 35(29):8385-93. PubMed ID: 24986256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of humoral and cell-mediated immune responses to cationic PLGA microspheres containing recombinant hepatitis B antigen.
    Saini V; Jain V; Sudheesh MS; Jaganathan KS; Murthy PK; Kohli DV
    Int J Pharm; 2011 Apr; 408(1-2):50-7. PubMed ID: 21291968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo evidence of oral vaccination with PLGA nanoparticles containing the immunostimulant monophosphoryl lipid A.
    Sarti F; Perera G; Hintzen F; Kotti K; Karageorgiou V; Kammona O; Kiparissides C; Bernkop-Schnürch A
    Biomaterials; 2011 Jun; 32(16):4052-7. PubMed ID: 21377204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
    Gupta NK; Tomar P; Sharma V; Dixit VK
    Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intradermal vaccination with hollow microneedles: A comparative study of various protein antigen and adjuvant encapsulated nanoparticles.
    Du G; Hathout RM; Nasr M; Nejadnik MR; Tu J; Koning RI; Koster AJ; Slütter B; Kros A; Jiskoot W; Bouwstra JA; Mönkäre J
    J Control Release; 2017 Nov; 266():109-118. PubMed ID: 28943194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancing immunogenicity to PLGA microparticulate systems by incorporation of alginate and RGD-modified alginate.
    Mata E; Igartua M; Patarroyo ME; Pedraz JL; Hernández RM
    Eur J Pharm Sci; 2011 Sep; 44(1-2):32-40. PubMed ID: 21699977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: A comparative study of cationic liposomes and PLGA nanoparticles.
    Varypataki EM; Silva AL; Barnier-Quer C; Collin N; Ossendorp F; Jiskoot W
    J Control Release; 2016 Mar; 226():98-106. PubMed ID: 26876760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles.
    Yang Y; Xie XY; Mei XG
    Drug Deliv; 2016; 23(3):787-93. PubMed ID: 24870204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid core peptide/poly(lactic-co-glycolic acid) as a highly potent intranasal vaccine delivery system against Group A streptococcus.
    Marasini N; Khalil ZG; Giddam AK; Ghaffar KA; Hussein WM; Capon RJ; Batzloff MR; Good MF; Skwarczynski M; Toth I
    Int J Pharm; 2016 Nov; 513(1-2):410-420. PubMed ID: 27659862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biodegradable intranasal nanoparticulate drug delivery system of risedronate sodium for osteoporosis.
    Fazil M; Hassan MQ; Baboota S; Ali J
    Drug Deliv; 2016 Sep; 23(7):2428-2438. PubMed ID: 25625496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficient nanoparticle-mediated needle-free transcutaneous vaccination via hair follicles requires adjuvantation.
    Mittal A; Schulze K; Ebensen T; Weißmann S; Hansen S; Lehr CM; Guzmán CA
    Nanomedicine; 2015 Jan; 11(1):147-54. PubMed ID: 25200611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune response and functional role of antibodies raised in heifers against a Staphylococcus aureus CP5 lysate and recombinant antigens vaccine formulated with Iscom Matrix adjuvant.
    Camussone CM; Pujato N; Renna MS; Veaute CM; Morein B; Marcipar IS; Calvinho LF
    Vet Immunol Immunopathol; 2014 Dec; 162(3-4):96-107. PubMed ID: 25454469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
    Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
    ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nafcillin-loaded PLGA nanoparticles for treatment of osteomyelitis.
    Pillai RR; Somayaji SN; Rabinovich M; Hudson MC; Gonsalves KE
    Biomed Mater; 2008 Sep; 3(3):034114. PubMed ID: 18708713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of systemic and mucosal immunity against methicillin-resistant Staphylococcus aureus infection by a novel nanoemulsion adjuvant vaccine.
    Sun H; Wei C; Liu B; Jing H; Feng Q; Tong Y; Yang Y; Yang L; Zuo Q; Zhang Y; Zou Q; Zeng H
    Int J Nanomedicine; 2015; 10():7275-90. PubMed ID: 26664118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intranasal vaccination with adjuvant-free S. aureus antigens effectively protects mice against experimental sepsis.
    Stegmiller NP; Barcelos EC; Leal JM; Covre LP; Donatele DM; de Matos Guedes HL; Cunegundes MC; Rodrigues RR; Gomes DC
    Vaccine; 2016 Jun; 34(30):3493-9. PubMed ID: 27091687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide.
    Kirby BP; Pabari R; Chen CN; Al Baharna M; Walsh J; Ramtoola Z
    J Pharm Pharmacol; 2013 Oct; 65(10):1473-81. PubMed ID: 24028614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mucoadhesive glycol chitosan nanoparticles for intranasal delivery of hepatitis B vaccine: enhancement of mucosal and systemic immune response.
    Pawar D; Jaganathan KS
    Drug Deliv; 2016; 23(1):185-94. PubMed ID: 24825494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diphtheria toxoid loaded poly-(epsilon-caprolactone) nanoparticles as mucosal vaccine delivery systems.
    Singh J; Pandit S; Bramwell VW; Alpar HO
    Methods; 2006 Feb; 38(2):96-105. PubMed ID: 16442811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel synthetic (poly)glycerolphosphate-based antistaphylococcal conjugate vaccine.
    Chen Q; Dintaman J; Lees A; Sen G; Schwartz D; Shirtliff ME; Park S; Lee JC; Mond JJ; Snapper CM
    Infect Immun; 2013 Jul; 81(7):2554-61. PubMed ID: 23649092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.